Abstract
This study investigates the effect of R&D capitalization on earnings variability. Investment in R&D plays a significant role in the world of business by leading to innovation, development, and the growth of business enterprises. However, the current accounting standards require corporations to expense the R&D costs as incurred. Accordingly, there has been a debate over the accounting treatment for such investment for decades. We calculate earnings (adjusted for R&D capitalization), as if the company's R&D expenditures were capitalized during the period and compare it with reported earnings in financial statements. We find that earnings reported in the financial statements are more variable when R&D spending changes significantly. It implies that financial reporting under R&D capitalization provides more reliable information. The findings of this study supports the argument that we should make changes from the current accounting treatment of R&D expensing to R&D capitalization, which may provide more value-relevant and reliable information on earnings.
| Original language | English |
|---|---|
| Pages (from-to) | 107-111 |
| Number of pages | 5 |
| Journal | Life Science Journal |
| Volume | 11 |
| Issue number | SPEC. ISSUE 7 |
| State | Published - 2014 |
Keywords
- Earnings variability
- Reliability
- Research and development